Hospital
The Children's Mercy Hospital
The Children's Mercy Hospital was paid $221.16M by Medicaid between Jan 2018 and Dec 2024, across 264 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 20% of everything it billed.
33Billing provider infoTHE CHILDREN'S MERCY HOSPITAL
KANSAS CITY, MO 64108
KANSAS CITY, MO 64108
33aNPI1366515488assigned 11/16/2006
33bProvider typeChildren's Hospital
28Total paid$221.16M
24GClaims1,044,499
24DCodes billed264
24AFirst – last monthJan 2018 – Dec 2024
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official FINUF, ROBERT controls 16+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 167,026 | $73.14M | |
| 2019 | 140,643 | $63.01M | |
| 2020 | 115,044 | $21.19M | |
| 2021 | 144,238 | $1.36M | |
| 2022 | 129,576 | $11.52M | |
| 2023 | 190,468 | $27.23M | |
| 2024incomplete | 157,504 | $23.70M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 20% | 268,474 | 261,078 | $44.56M |
| X4011 | State-specific procedure code | 13% | 32,889 | 32,129 | $29.67M |
| X4003 | 11% | 154,516 | 149,483 | $24.31M | |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 9.1% | 65,810 | 64,426 | $20.10M |
| X4014 | 8.1% | 13,063 | 12,996 | $17.88M | |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 3.3% | 18,728 | 18,521 | $7.35M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.1% | 99,588 | 95,213 | $4.61M |
| 87400 | 2.0% | 5,916 | 2,951 | $4.37M | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.8% | 11,531 | 11,057 | $4.09M |
| 87430 | 1.8% | 7,069 | 7,007 | $3.96M | |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.8% | 26,017 | 23,538 | $3.96M |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.5% | 21,595 | 19,043 | $3.30M |
252 more codes
| 99285 | Emergency room visit (most serious) | 1.4% | 5,229 | $3.12M |
| 93325 | 1.3% | 4,492 | $2.95M | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.2% | 9,838 | $2.73M |
| 80076 | 1.2% | 19,957 | $2.62M | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.2% | 12,729 | $2.56M |
| 87081 | 1.1% | 11,011 | $2.49M | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 7,688 | $1.56M |
| J3490 | Unclassified drugs | <1% | 2,343 | $1.36M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 44,987 | $1.30M |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 256 | $1.27M |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 3,249 | $1.14M |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,115 | $1.13M |
| 85027 | <1% | 12,268 | $1.08M | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 1,376 | $1.02M |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | <1% | 1,027 | $987K |
| 86140 | <1% | 6,575 | $985K | |
| X4006 | <1% | 296 | $943K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 2,711 | $914K |
| 93320 | <1% | 781 | $877K | |
| 76770 | <1% | 3,503 | $845K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 12,618 | $845K |
| 85652 | <1% | 5,603 | $834K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 10,579 | $769K |
| 93304 | <1% | 1,665 | $743K | |
| 80061 | Lipid panel | <1% | 9,203 | $728K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 916 | $720K |
| 83655 | <1% | 5,802 | $705K | |
| 72082 | <1% | 2,927 | $662K | |
| 29075 | <1% | 2,097 | $649K | |
| 86003 | <1% | 1,517 | $648K | |
| 95819 | <1% | 1,720 | $615K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 2,012 | $614K |
| 93321 | <1% | 2,065 | $567K | |
| 81003 | <1% | 2,958 | $553K | |
| 94010 | <1% | 2,987 | $476K | |
| 73620 | <1% | 587 | $464K | |
| 73140 | <1% | 1,503 | $462K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 258 | $453K |
| 82977 | <1% | 3,224 | $447K | |
| 73100 | <1% | 3,083 | $391K | |
| 85046 | <1% | 2,680 | $358K | |
| 81001 | <1% | 923 | $343K | |
| 81025 | <1% | 2,511 | $322K | |
| 82728 | <1% | 3,640 | $317K | |
| 84439 | <1% | 7,140 | $311K | |
| 96415 | <1% | 662 | $243K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 2,448 | $243K |
| 92523 | <1% | 624 | $234K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 11,207 | $228K |
| 72170 | <1% | 1,855 | $226K | |
| 81415 | <1% | 51 | $225K | |
| 83615 | <1% | 1,543 | $207K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 1,795 | $200K |
| 16020 | <1% | 754 | $194K | |
| 83021 | <1% | 365 | $189K | |
| 81443 | <1% | 94 | $182K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 600 | $169K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 3,208 | $167K |
| 73090 | <1% | 1,014 | $166K | |
| 92567 | <1% | 3,290 | $162K | |
| 95812 | <1% | 237 | $161K | |
| 86703 | <1% | 338 | $150K | |
| 74018 | <1% | 1,229 | $145K | |
| 83880 | <1% | 309 | $144K | |
| 86803 | <1% | 194 | $137K | |
| 87631 | <1% | 150 | $132K | |
| 87340 | <1% | 184 | $130K | |
| 86706 | <1% | 183 | $130K | |
| 86704 | <1% | 183 | $130K | |
| 94664 | <1% | 568 | $112K | |
| 87077 | <1% | 481 | $97K | |
| 82550 | <1% | 1,025 | $93K | |
| 86900 | <1% | 626 | $92K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 2,897 | $88K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 710 | $81K |
| G0378 | Hospital observation service, per hour | <1% | 149 | $79K |
| 86901 | <1% | 612 | $79K | |
| 82570 | <1% | 1,330 | $73K | |
| 86885 | <1% | 426 | $69K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 429 | $68K |
| 87634 | <1% | 1,440 | $65K | |
| 81407 | <1% | 29 | $63K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 3,225 | $62K |
| 97161 | <1% | 313 | $56K | |
| 29065 | <1% | 192 | $56K | |
| 84100 | <1% | 1,490 | $50K | |
| 83970 | <1% | 461 | $50K | |
| 87040 | <1% | 45 | $47K | |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | <1% | 13 | $47K |
| 87186 | <1% | 263 | $44K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,027 | $43K |
| 83735 | <1% | 1,054 | $42K | |
| 16025 | <1% | 158 | $42K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 974 | $41K |
| 85610 | <1% | 208 | $39K | |
| 73070 | <1% | 213 | $38K | |
| 83540 | <1% | 171 | $35K | |
| 81229 | <1% | 64 | $33K | |
| 41899 | Unlisted procedure, dentoalveolar structures | <1% | 27 | $33K |
| 92133 | <1% | 190 | $33K | |
| 93786 | <1% | 365 | $33K | |
| 86923 | <1% | 24 | $32K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 191 | $32K |
| 92504 | <1% | 350 | $31K | |
| 84156 | <1% | 691 | $28K | |
| 95117 | <1% | 1,185 | $28K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 169 | $28K |
| 85240 | <1% | 101 | $27K | |
| 82784 | <1% | 684 | $27K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 290 | $26K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 204 | $25K |
| 87210 | <1% | 76 | $24K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 51 | $24K |
| 92526 | <1% | 383 | $22K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,674 | $22K |
| 86902 | <1% | 78 | $21K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 106 | $21K |
| 72081 | <1% | 121 | $21K | |
| 77072 | <1% | 161 | $20K | |
| 85730 | <1% | 68 | $20K | |
| 84460 | <1% | 1,033 | $20K | |
| 86160 | <1% | 116 | $20K | |
| 62370 | <1% | 194 | $19K | |
| P9040 | Red blood cells, leukocytes reduced, irradiated, each unit | <1% | 69 | $19K |
| 74019 | <1% | 53 | $18K | |
| 84450 | <1% | 700 | $17K | |
| 86592 | <1% | 13 | $16K | |
| 84550 | <1% | 618 | $16K | |
| 76825 | <1% | 25 | $14K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 101 | $14K |
| 73590 | <1% | 322 | $13K | |
| 83516 | <1% | 410 | $13K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 44 | $13K |
| 84305 | <1% | 231 | $13K | |
| 95816 | <1% | 52 | $12K | |
| 96040 | <1% | 443 | $12K | |
| 17110 | <1% | 31 | $11K | |
| 96409 | <1% | 79 | $10K | |
| 82785 | <1% | 372 | $8K | |
| 86038 | <1% | 42 | $8K | |
| 86800 | <1% | 310 | $7K | |
| 93308 | <1% | 38 | $7K | |
| 86376 | <1% | 319 | $6K | |
| 90686 | <1% | 1,099 | $6K | |
| 43762 | <1% | 26 | $6K | |
| 80197 | <1% | 474 | $6K | |
| 62369 | <1% | 28 | $5K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 382 | $5K |
| 87070 | <1% | 74 | $5K | |
| 87205 | <1% | 64 | $5K | |
| 31575 | <1% | 27 | $5K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 39 | $5K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 791 | $5K |
| 97165 | <1% | 59 | $4K | |
| 80069 | <1% | 424 | $4K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 26 | $4K |
| 87101 | <1% | 41 | $4K | |
| 43760 | <1% | 13 | $4K | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 130 | $4K |
| 92610 | <1% | 38 | $3K | |
| 92579 | <1% | 25 | $3K | |
| 86364 | <1% | 280 | $3K | |
| J3535 | Drug administered through a metered dose inhaler | <1% | 79 | $3K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 106 | $3K |
| 80180 | <1% | 203 | $3K | |
| 16000 | <1% | 14 | $2K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 24 | $2K |
| 92524 | <1% | 37 | $2K | |
| 71045 | Radiologic examination, chest; single view | <1% | 43 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 187 | $2K |
| 73552 | <1% | 58 | $2K | |
| 86780 | <1% | 116 | $2K | |
| 83550 | <1% | 169 | $2K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 22 | $2K |
| 76827 | <1% | 13 | $2K | |
| 73610 | <1% | 14 | $2K | |
| 87799 | <1% | 54 | $2K | |
| 85397 | <1% | 49 | $1K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 14 | $1K |
| 92015 | Determination of refractive state | <1% | 245 | $1K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 14 | $1K |
| 85246 | <1% | 57 | $1K | |
| 83002 | <1% | 43 | $1K | |
| 83001 | <1% | 42 | $1K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 33 | $936.64 |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 13 | $887.62 |
| 84478 | <1% | 108 | $756.65 | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 42 | $722.24 |
| 95012 | <1% | 27 | $702.55 | |
| 90723 | <1% | 24 | $642.00 | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 12 | $590.28 |
| 80074 | <1% | 12 | $536.25 | |
| 82610 | <1% | 41 | $523.02 | |
| 92587 | <1% | 70 | $521.67 | |
| 93296 | <1% | 13 | $515.08 | |
| 97803 | <1% | 185 | $503.84 | |
| 82040 | <1% | 89 | $463.43 | |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 182 | $452.78 |
| 90670 | <1% | 80 | $430.68 | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 26 | $417.30 |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 25 | $401.25 |
| 92134 | <1% | 14 | $395.90 | |
| 84403 | <1% | 12 | $388.83 | |
| 82670 | <1% | 12 | $377.73 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 501 | $375.70 |
| 83498 | <1% | 14 | $333.34 | |
| 85660 | <1% | 51 | $332.14 | |
| 51701 | <1% | 13 | $310.52 | |
| 74022 | <1% | 13 | $309.50 | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 465 | $307.55 |
| 82627 | <1% | 17 | $306.45 | |
| 82565 | <1% | 38 | $300.61 | |
| 87147 | <1% | 33 | $297.37 | |
| 83020 | <1% | 14 | $297.12 | |
| 87420 | <1% | 27 | $288.70 | |
| 84630 | <1% | 14 | $283.27 | |
| 76536 | <1% | 12 | $282.74 | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 15 | $277.70 |
| L3908 | Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf | <1% | 57 | $239.08 |
| 83690 | <1% | 30 | $239.00 | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 12 | $196.61 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 88 | $193.46 |
| 82310 | <1% | 32 | $191.55 | |
| J9370 | Vincristine sulfate, 1 mg | <1% | 19 | $177.59 |
| 85007 | <1% | 64 | $174.42 | |
| 82043 | <1% | 29 | $170.72 | |
| 82104 | <1% | 12 | $168.66 | |
| 97802 | <1% | 27 | $163.95 | |
| 82103 | <1% | 12 | $160.09 | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 13 | $147.27 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 46 | $139.64 |
| 73130 | <1% | 41 | $131.53 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 155 | $126.80 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 209 | $124.66 |
| 86015 | <1% | 12 | $123.75 | |
| 82390 | <1% | 12 | $122.99 | |
| 84030 | <1% | 30 | $120.13 | |
| 86431 | <1% | 13 | $109.69 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 159 | $106.38 |
| 82150 | <1% | 13 | $100.74 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 93 | $90.11 |
| J2704 | Injection, propofol, 10 mg | <1% | 193 | $83.83 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 72 | $63.49 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 90 | $56.64 |
| 81015 | <1% | 12 | $51.15 | |
| Y7506 | <1% | 108 | $50.84 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 31 | $20.35 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 33 | $14.81 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 19 | $11.89 |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 33 | $1.53 |
| Y7507 | 0% | 26 | $0.00 | |
| 84436 | 0% | 55 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFINUF, ROBERT (SENIOR VICE PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| The Children's Mercy Hospital | Kansas City, MO | $53.57M |
| The Children's Mercy Hospital | Riverside, MO | $28.27M |
| The Children's Mercy Hospital | Overland Park, KS | $22.32M |
| The Children's Mercy Hospital | Kansas City, MO | $13.40M |
| Children's Mercy-Community Choice Pediatrics | Lees Summit, MO | $8.95M |
| Children's Mercy-Cockerell and Mcintosh Pediatrics, INC | Blue Springs, MO | $6.34M |
| Children's Mercy-Preferred Pediatrics | Lees Summit, MO | $2.92M |
| The Children's Mercy Hospital | Riverside, MO | $2.34M |
| Children's Mercy - Peacock Pediatrics, INC | Saint Joseph, MO | $1.29M |
| Children's Mercy - Cass County Pediatrics & Adolescents | Belton, MO | $1.12M |
| Children's Mercy - Pediatric Partners, INC | Overland Park, KS | $459K |
| The Children's Mercy Hospital | Riverside, MO | $334K |
| Children's Mercy - Redwood Pediatrics | Kansas City, MO | $246K |
| Children's Mercy - Wildwood Pediatrics | Lees Summit, MO | $6K |
| The Childrens Mercy Hospital | Kansas City, MO | $4K |
| The Children's Mercy Hospital | Kansas City, MO | $54.40 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.